 |
| A new Huawei wearable has been rumored |
Huawei is quietly building on its reputation for innovative health technology in wearables. Following the introduction of its first blood glucose tracking feature on the Watch 4 in 2023 and the recent announcement of a new Diabetes Risk Study feature for models like the Huawei Watch GT 6 Pro (curr. €314.90 at Amazon DE), the company is now reportedly preparing its most advanced health wearable yet.
According to a new leak from the well-known Weibo tipster Fixed-Focus Digital (定焦数码), Huawei is developing another wearable dedicated to blood sugar monitoring. The key upgrade? The source claims the new model’s technology will be “more precise” than its predecessors, aiming to provide users with even more reliable data for managing their health.
While specific technical details on how this improved accuracy is achieved weren't provided in the leak, the information points to a significant step forward for non-invasive glucose tracking technology.
A New Version of the Watch D?
The tipster’s post has led to speculation about which device this will be. According to Huawei Central, a reputable blog covering the company, this new wearable is likely the next generation of the Huawei Watch D.
The Watch D series has been Huawei’s dedicated line for advanced health monitoring, previously focusing on medical-grade blood pressure measurement. The current model, the Watch D2, uses a sophisticated TruSense system with micro air pumps and airbags for accurate blood pressure readings. Integrating a "more precise" blood glucose sensor into this existing health-focused platform would be a logical and powerful evolution, creating a comprehensive health management tool on your wrist.
When Can We Expect It?
For those eager to get their hands on this new technology, the leak provides a tentative timeline. Fixed-Focus Digital suggests that Huawei will officially launch its new blood sugar monitoring wearable in Q2 2026.
This places the release window sometime between early April and the end of June next year. This timeline gives Huawei several months to finalize the technology and prepare for production.
Will It Launch Globally?
A significant question remains about availability. Huawei’s first blood glucose tracking feature, launched with the Watch 4 in 2023, was exclusive to devices sold in China. Similarly, while the new device is confirmed to be in development, it is still unclear whether this "more precise" model will see a global release.
Given the increasing global demand for advanced health monitoring features in smartwatches, a worldwide launch would be a major move for Huawei. However, until the company makes an official announcement, potential buyers in markets like Europe and North America will have to watch this space closely.
For now, the leak confirms that Huawei is doubling down on its commitment to non-invasive health monitoring, with a goal to make managing blood sugar levels more accurate and accessible than ever before.
Source(s): Weibo (via Fixed-Focus Digital), Huawei Central
 |
| A screenshot of the Fixed-Focus Digital (定焦数码) Weibo post (machine translated) |